SFTPD and idiopathic pulmonary fibrosis: Taken together, the present study findings support the view that both well-established circulating IPF biomarkers, including KL-6, SP-D, and MMP-7, and more recently introduced ones, like CA19-9, have the potential to support clinical practice in IPF.